Sign in Subscribe

Admin

Stroke

Stroke

SPECIAL REPORT #22.5 Stroke Stroke ranks as the third cause of death in the world after ischaemic heart disease and the cumulative cancer diseases. Each year, about 20 million strokes occur in the world causing a total of 7.2 million death. Stroke is a global epidemic which affects

Human Induced Pluripotent Stem Cells as Innovative Therapies

Human Induced Pluripotent Stem Cells as Innovative Therapies

SPECIAL REPORT #21.26 Human Induced Pluripotent Stem Cells as Innovative Therapies When, in 2007, Professor Shinya Yamanaka disclosed its discovery that mature human cells could be transformed into stem cells, better known now as human induced Pluripotent Stem Cells (hiPSC), the biopharmaceutical community immediately recognised that this new biological

The FDA grants an accelerated approval for Biogen’s aducanumab for the treatment of Alzheimer’s disease

The FDA grants an accelerated approval for Biogen’s aducanumab for the treatment of Alzheimer’s disease

SPECIAL REPORT #21.17 The FDA grants an accelerated approval for Biogen’s aducanumab for the treatment of Alzheimer’s disease The U. S.

Artificial Intelligence used to discover a potent antibiotic

Artificial Intelligence used to discover a potent antibiotic

SPECIAL REPORT #20.6 Artificial Intelligence is an extremely powerful tool to analyse massive existing data, to identify unknown trends and even to decipher unexpected correlations. The technology is now being used in almost every single economic and industrial sector, including R&D and more recently in prospective discovery.

Hearing loss: A major unmet medical need.

Hearing loss: A major unmet medical need.

SPECIAL REPORT #20.3 Hearing loss: A major unmet medical need.

Parallèles entre exploration spatiale et exploration du cerveau

Parallèles entre exploration spatiale et exploration du cerveau

Posté le 6 novembre 2019 dans un Communiqués de presse par Charles Sagnes. L’exploration spatiale et l’exploration du cerveau, deux domaines qui semblent très éloignés sur le papier, ont, en fait, beaucoup de points communs et peuvent chacun apprendre l’un de l’autre pour le futur. Alcimed,

China approves Oligomannate for the treatment of Alzheimer’s disease

China approves Oligomannate for the treatment of Alzheimer’s disease

“Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease”.